IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2008 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded93    
    Comments [Add]    

Recommend this journal


Year : 1999  |  Volume : 31  |  Issue : 4  |  Page : 315-318

Expression of inducible and neuronal nitric oxide synthase in 20-methyl cholanthrene (20-MCA) induced fibrosarcoma

Correspondence Address:
S Sengupta

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Objective: Studies have shown that expression and localisation of nitric oxide synthase (NOS) depends on the type and differentiation status of different types of tumours. The present study was conducted to evaluate the expression of NOS in carcinogen induced tumour. Method: Swiss albino mice were injected with 20-methyl cholanthrene. Seventy six percent of the animals were positive for fibrosarcoma at the end of 100 days following exposure. The tumours were excised when they reached a predetermined size and immunostained for inducible and neuronal NOS. The staining was graded on an increasing intensity scale. Results: The tumour sections stained very strongly for iNOS as compared to controls (identical sections from tumour negative mice). Weak staining was detected for nNOS in the tumour sections unlike controls. Conclusions: NO may be involved in carcinogen induced fibrosarcoma as seen from the expression of its synthesising enzymes.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow